Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 7.56
+0.01 (0.13%)
Feb 13, 2026, 4:08 PM HKT
HKG:0512 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 2,079 | 2,468 | 1,880 | 2,079 | 2,403 | 1,793 |
Depreciation & Amortization | 540.01 | 503.75 | 392.21 | 394.91 | 339.52 | 287.06 |
Loss (Gain) From Sale of Assets | 1 | 1 | 13.06 | 0.18 | 1.55 | -4.99 |
Asset Writedown & Restructuring Costs | 44.7 | 44.7 | 50.14 | 26.36 | 1.51 | -38.64 |
Loss (Gain) From Sale of Investments | -675.93 | -675.93 | -89.27 | 94.62 | -483.68 | -264.97 |
Loss (Gain) on Equity Investments | -148.72 | -148.72 | 25.01 | 43.79 | -113.86 | -61.98 |
Provision & Write-off of Bad Debts | 72.98 | 72.98 | 57.7 | -22.64 | 11.77 | 9.89 |
Other Operating Activities | 254.15 | 52.42 | 219.23 | 119.75 | 144.97 | -36.3 |
Change in Accounts Receivable | -444.4 | -444.4 | -177.52 | -514.24 | -701.65 | -122.23 |
Change in Inventory | 74.54 | 74.54 | -99.41 | -295.28 | -118.74 | -100.96 |
Change in Accounts Payable | -174.31 | -174.31 | 290.65 | -234.58 | 605.5 | 2.49 |
Change in Unearned Revenue | 135.85 | 135.85 | -110.66 | 154.96 | -64.09 | -36.96 |
Change in Other Net Operating Assets | -12.17 | -12.17 | -26.24 | -3.78 | -19.67 | 30.06 |
Operating Cash Flow | 1,747 | 1,898 | 2,425 | 1,843 | 2,006 | 1,456 |
Operating Cash Flow Growth | -8.18% | -21.73% | 31.60% | -8.13% | 37.76% | 11.66% |
Capital Expenditures | -561.48 | -555.78 | -487.73 | -626.22 | -471.57 | -209.01 |
Sale of Property, Plant & Equipment | 0.97 | 0.97 | 6.61 | 1.99 | 23.79 | 1.53 |
Cash Acquisitions | -779.92 | -1,179 | -176.42 | -269.22 | -245.41 | - |
Sale (Purchase) of Intangibles | -91.73 | -41.25 | -0.31 | -431.37 | -64.8 | -49.56 |
Investment in Securities | 447.84 | -180.89 | -5.17 | -639.34 | -1,200 | -1,415 |
Other Investing Activities | -49.88 | -41.78 | 147.27 | -395.95 | 142.42 | 319.29 |
Investing Cash Flow | -1,034 | -1,997 | -515.75 | -2,360 | -1,769 | -1,513 |
Long-Term Debt Issued | - | 4,481 | 2,370 | 3,117 | 1,981 | 2,142 |
Long-Term Debt Repaid | - | -3,342 | -3,451 | -2,210 | -1,621 | -1,926 |
Net Debt Issued (Repaid) | 9.53 | 1,139 | -1,081 | 906.49 | 359.6 | 215.62 |
Issuance of Common Stock | - | - | - | - | - | 1,014 |
Repurchase of Common Stock | - | - | -81.01 | -43.99 | -143.5 | - |
Common Dividends Paid | -898.05 | -910.47 | -496.94 | -390.45 | -390.45 | -324.25 |
Other Financing Activities | -182.15 | -198.26 | -230.08 | -145.05 | -158.82 | -130.77 |
Financing Cash Flow | -1,071 | 29.96 | -1,889 | 327 | -333.17 | 774.27 |
Foreign Exchange Rate Adjustments | 102.3 | 70.56 | -124.06 | -118.42 | 12.64 | 60.37 |
Net Cash Flow | -255.4 | 1.27 | -104.31 | -308.85 | -83.84 | 777.43 |
Free Cash Flow | 1,186 | 1,342 | 1,937 | 1,216 | 1,534 | 1,247 |
Free Cash Flow Growth | -18.25% | -30.71% | 59.25% | -20.71% | 23.03% | 68.98% |
Free Cash Flow Margin | 10.13% | 11.53% | 18.40% | 12.72% | 17.84% | 19.63% |
Free Cash Flow Per Share | 0.34 | 0.38 | 0.55 | 0.34 | 0.43 | 0.36 |
Cash Interest Paid | 169.07 | 180.24 | 204.36 | 137.49 | 92.96 | 115.42 |
Cash Income Tax Paid | 480.24 | 480.24 | 471.08 | 349.26 | 277.32 | 259.91 |
Levered Free Cash Flow | 309.46 | 683.25 | 1,544 | 460.64 | 1,294 | 1,159 |
Unlevered Free Cash Flow | 418.51 | 795.9 | 1,672 | 546.57 | 1,352 | 1,231 |
Change in Working Capital | -420.48 | -420.48 | -123.18 | -892.92 | -298.63 | -227.61 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.